Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 97 Breast Neoplasms 81 Lung Neoplasms 50 Prostatic Neoplasms 38 Carcinoma, Non-Small-Cell Lung 35 Colorectal Neoplasms 32 Pancreatic Neoplasms 30 Hematologic Neoplasms 25 Brain Neoplasms 21 Lymphoma 20 Ovarian Neoplasms 18 Melanoma 17 Urinary Bladder Neoplasms 16 Liver Neoplasms 16 Head and Neck Neoplasms 16 Stomach Neoplasms 15 Multiple Myeloma 15 Leukemia, Myeloid, Acute 15 Carcinoma, Hepatocellular 15 Leukemia 14 Carcinoma, Renal Cell 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Kidney Neoplasms 13 Esophageal Neoplasms 13 Lymphoma, Non-Hodgkin 12 Leukemia, Lymphocytic, Chronic, B-Cell 12 Disease 12 Uterine Cervical Neoplasms 11 Cardiovascular Diseases 10 Rectal Neoplasms 9

Interventions

Tablets 1 Genetic Testing 1 Everolimus 1 Blood Specimen Collection 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hormone Receptor Positive Breast Cancer × 30 days × Clear all

NCT07646171 2026-06-12

MBC

Tel-Aviv Sourasky Medical Center

Hormone Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡